Health

  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Home
  • Business
    • Internet
    • Market
    • Stock
  • Downloads
    • Dvd
    • Games
    • Software
      • Office
  • Parent Category
    • Child Category 1
      • Sub Child Category 1
      • Sub Child Category 2
      • Sub Child Category 3
    • Child Category 2
    • Child Category 3
    • Child Category 4
  • Featured
  • Health
    • Childcare
    • Doctors
  • Uncategorized

Tuesday, July 18, 2023

New dementia drug 'has given me hope’: Alzheimer’s patients reveal their stories

 July 18, 2023     Health, Health News Today on Fox News     No comments   

The first new Alzheimer’s treatment in 20 years was given full FDA approval earlier this month — and now two patients who participated in the clinical trials have spoken about their personal experience with the drug to Fox News Digital.

Lecanemab, sold under the brand name Leqembi, works by reducing amyloid plaques in the brain, which is one of the hallmarks of Alzheimer’s. 

In early trials, the drug was shown to slow cognitive decline by 27%.

FDA FULLY APPROVES 'NOVEL' ALZHEIMER’S DISEASE DRUG LEQEMBI, WILL BE COVERED BY MEDICARE

Two Ohio patients who participated in the trials recently spoke to Fox News Digital about how Leqembi has impacted their Alzheimer’s journeys — and changed their lives.

Joan Murtaugh, 77, lives in Lakewood, Ohio, with her husband, Larry. 

She first started noticing memory problems nearly seven years ago, just after her 70th birthday.

"Timing is everything," her husband, Larry Murtaugh, told Fox News Digital in an interview. "It was Joan who made an appointment at the brain center clinic."

In 2017, Murtaugh was diagnosed with mild cognitive impairment. 

The next year, after having a 3-D MRI and spinal tap, she learned that she had an enzyme in her spinal fluid that predicted a 65% chance of getting Alzheimer’s in her lifetime. 

In February 2020, Murtaugh received some good news: She was eligible to participate in a double-blind study trial for a new drug, Leqembi, at Cleveland Clinic in Ohio. 

"I assume it was because it was obvious there was some plaque in my brain, which they realized was causing Alzheimer’s," Murtaugh told Fox News Digital.

This was Phase 3 of the clinical trial, which included some 1,800 people worldwide. Murtaugh was one of only eight people to receive the drug at Cleveland Clinic.

A few months later, she began getting twice-monthly infusions of what was either a drug or a placebo.

ALZHEIMER’S DISEASE IS MOST COMMON IN THESE US COUNTIES, NEW STUDY FINDS

To this day, Murtaugh still doesn’t know if she was getting the real thing or a placebo — she won’t find out until the very last person has received the very last dose of the double-blind study. Yet she said she "has a hunch."

"I am fully functional — I’m still doing everything I always did," Murtaugh said. 

"I can still drive my car, shop, garden, cook, read — all those things."

Throughout the entire trial period, Murtaugh said she never got any worse. She just experienced the same mild symptoms she’d had before starting the drug — and she may have even improved a bit. 

Although Leqembi has been linked to some potential side effects, she experienced none.

"When you first hear the word ‘Alzheimer’s,’ a chill goes through you — it’s like you’re looking into a dark abyss," Murtaugh said. 

"But this new drug offers great hope."

VISION PROBLEMS COULD MEAN HIGHER DEMENTIA RISK, STUDY FINDS: 'EYE HEALTH AND BRAIN HEALTH ARE CLOSELY LINKED'

In September 2021, the trial portion of the study ended and Murtaugh was eligible to start receiving the actual medication, which she still takes today. 

Instead of the lengthy infusions, she now gets the medication via an EpiPen injection once a week with the help of her husband.

The drug is currently covered by Medicare, which means Murtaugh gets it for free — and she hopes that will continue for the foreseeable future.

While the Murtaughs realize that the future may bring challenges, they regard Leqembi as "a ray of sunshine in a very cloudy sky."

Paired with other approaches such as cognitive speech therapy, they’re optimistic that the drug will continue to keep Alzheimer’s symptoms at bay.

"We’re not going to declare victory, but we’re on the right path and we have the right team at Cleveland Clinic," said Larry Murtaugh. 

"It’s not a miracle, but it’s gradual progress."

A retired attorney in Aurora, Ohio, John Domeck was just 57 years old when he was diagnosed with Alzheimer’s.

The people around him — his colleagues at the law office and his family at home — started noticing his memory lapses before he did.

After 30 years of never having to take many notes at work, Domeck, now 61, had started to write things down to avoid forgetting them.

"Over time, I wasn't able to continue doing as much work as quickly as I once did," he told Fox News Digital during an interview.

His wife of 40 years, Ann Domeck, had also started noticing some red flags at home, but said the last thing they expected was Alzheimer's disease.

The Domecks made an appointment at Cleveland Clinic for some cognitive testing, which led to a spinal tap and, ultimately, an Alzheimer’s diagnosis in July 2019.

Domeck’s wife, a TV news producer in Cleveland, left her job to help care for her husband.

Given Domeck’s young age and early-stage decline, a Cleveland Clinic doctor told him he was the perfect candidate for a clinical trial for a new Alzheimer’s drug.

For 18 months, Domeck went in for twice-monthly infusions, which lasted up to six hours per session — without knowing whether he was getting the drug or the placebo.

A year ago, he was switched to the "open-label" Leqembi medication, which he takes via injection at home once a week.

SURPRISING BRAIN BOOST: BRUSHING YOUR TEETH MAY REDUCE THE RISK OF DEMENTIA, NEW STUDY SUGGESTS

The Domecks suspect that John has been on the drug the entire time, as he has not declined much at all in the past four years.

"Everyone's like, he had to have been getting it before — he's doing so well," Ann Domeck said. "His cognitive deficits have only increased minimally. After four years of Alzheimer’s, his scores should be a lot lower."

"The fact that he’s still able to maintain his day-to-day activities and do the things that he enjoys is just so promising," she added.

"John gets up and drives and golfs and reads every day," she said. "He got to see our son get married, and we’re planning to visit our daughter in Europe."

Throughout the process, the Domecks said they have been "astounded" by the compassion and support of their care team at Cleveland Clinic.

"They're professionals, and they know their stuff about Alzheimer's, but they're also some of the nicest people we've ever met," Ann Domeck said. 

While the couple understand that Leqembi is not a cure, they’re more optimistic now than they were a few years ago. 

"Alzheimer's kind of rocked our world, and this drug kind of rocked it back a little bit the other way," said Ann Domeck. 

After initially being "shell-shocked" by the unexpected diagnosis, the Domecks feel that the drug has given them time they were told not to expect.

"I thank God every day that we got in this trial," Ann Domeck said. "It's the best thing that's happened to us."

While it's the first Alzheimer’s drug to receive full FDA approval in 20 years, Leqembi is also the first medication to target the underlying disease and not just the symptoms, explained Dylan Wint, M.D., director of the Cleveland Clinic Lou Ruvo Center for Brain Health in Las Vegas, Nevada.

Leqembi is approved only for the treatment of mild cognitive impairment or early-stage Alzheimer's for people who have been shown to have amyloid plaques in the brain.

"Lecanemab labels abnormal amyloid and tells the immune cells to remove those fibers from the brain," Wint told Fox News Digital. 

In testing, about two-thirds of patients went from amyloid positive to amyloid negative — and cognitive and functional decline was 27% slower for study participants compared to those on placebo, the doctor said.

AI GIVES DOCTORS PERSONALIZED TREATMENT PLANS FOR DEMENTIA PATIENTS

"Taking this drug is a long-term commitment," said Wint. "Doctors need to make sure the patient can tolerate this rigorous regimen — intravenous infusions every two weeks for 18 months, interspersed with MRI scans and memory testing."

More care and support are needed for people with moderate and severe Alzheimer’s disease and their families, not to mention people with other forms of dementia, he added.

As with any medication, lecanemab can have some side effects. 

Most commonly, it can cause various brain reactions, like swelling and bleeding, explained Manisha Parulekar, M.D., co-director of Hackensack University Medical Center’s Center for Memory Loss & Brain Health in New Jersey.

"Patients will have to stop the medication if these changes are noted on MRIs," Parulekar told Fox News Digital. "People who are taking multiple blood thinners will not be able to take Leqembi."

Headaches and confusion are also commonly reported. 

CLICK HERE TO SIGN UP FOR OUR HEALTH NEWSLETTER

Now that Leqembi is fully approved, Medicare will cover the medication, with other insurance companies likely to follow, said Parulekar.

"Without Medicare or insurance, the out-of-pocket costs are around $26,000 per year," she noted. 

Alzheimer’s disease involves many complex factors, Wint noted, and the new medication targets just one factor: amyloid. 

"While this new approach is excellent news, removing amyloid is not a cure," he said. 

"We still need to find better symptomatic and disease-modifying treatments in the future." 

Leqembi is most effective when combined with existing treatments, said Wint, including symptomatic medicines, rehabilitation and family support.



from Health News Today on Fox News https://ift.tt/Bm9vj7J
  • Share This:  
  •  Facebook
  •  Twitter
  •  Google+
  •  Stumble
  •  Digg
Email ThisBlogThis!Share to XShare to Facebook

Related Posts:

  • High blood pressure and Alzheimer’s disease could go hand in hand, study findsThe risk of Alzheimer’s disease could escalate along with high blood pressure, according to a new study. Published in the medical journal Neurology, t… Read More
  • Cure for men's hair loss could be found in sugar stored in the body, study suggestsThe cure for male pattern baldness could already be in the human body. The condition, which causes gradual hair loss, affects up to 50% of men worldwi… Read More
  • With Mpox a public health emergency in Africa, what you must know about increased virus riskMpox (formerly monkeypox) has officially been declared a public health emergency by the Africa Centers for Disease Control and Prevention (CDC). The A… Read More
  • Sweden reports first case of highly-infectious mpox virus outside Africa amid outbreak thereSwedish health authorities announced the first case of the highly-infectious mpox just a day after the World Health Organization declared a global eme… Read More
  • 'Gender-affirming' breast removal surgeries may have been performed on hundreds of young girls since 2017Since 2017, hundreds of females age 12 and younger with gender dysmorphia have undergone double mastectomies, according to analysis released by the Ma… Read More
Newer Post Older Post Home

0 comments:

Post a Comment

Popular Posts

  • FOX NEWS: Losing weight could reduce breast cancer risk for women over 50, study finds
    Losing weight could reduce breast cancer risk for women over 50, study finds Overweight women over the age of 50 could see a reduction ...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD

Recent Posts

Categories

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Unordered List

Pages

  • Home

Text Widget

Blog Archive

  • May 2025 (85)
  • April 2025 (84)
  • March 2025 (88)
  • February 2025 (70)
  • January 2025 (72)
  • December 2024 (81)
  • November 2024 (70)
  • October 2024 (82)
  • September 2024 (75)
  • August 2024 (82)
  • July 2024 (79)
  • June 2024 (74)
  • May 2024 (73)
  • April 2024 (78)
  • March 2024 (75)
  • February 2024 (78)
  • January 2024 (78)
  • December 2023 (60)
  • November 2023 (80)
  • October 2023 (74)
  • September 2023 (75)
  • August 2023 (85)
  • July 2023 (67)
  • June 2023 (58)
  • May 2023 (100)
  • April 2023 (105)
  • March 2023 (118)
  • February 2023 (84)
  • January 2023 (87)
  • December 2022 (69)
  • November 2022 (64)
  • October 2022 (78)
  • September 2022 (74)
  • August 2022 (110)
  • July 2022 (109)
  • June 2022 (127)
  • May 2022 (95)
  • April 2022 (109)
  • March 2022 (140)
  • February 2022 (138)
  • January 2022 (170)
  • December 2021 (182)
  • November 2021 (213)
  • October 2021 (506)
  • September 2021 (539)
  • August 2021 (564)
  • July 2021 (590)
  • June 2021 (556)
  • May 2021 (544)
  • April 2021 (310)
  • March 2021 (331)
  • February 2021 (301)
  • January 2021 (326)
  • December 2020 (521)
  • November 2020 (403)
  • October 2020 (537)
  • September 2020 (554)
  • August 2020 (431)
  • July 2020 (647)
  • June 2020 (610)
  • May 2020 (659)
  • April 2020 (681)
  • March 2020 (729)
  • February 2020 (564)
  • January 2020 (483)
  • December 2019 (396)
  • November 2019 (416)
  • October 2019 (526)
  • September 2019 (486)
  • August 2019 (441)
  • July 2019 (394)
  • June 2019 (381)
  • May 2019 (510)
  • April 2019 (471)
  • March 2019 (560)
  • February 2019 (403)
  • January 2019 (530)
  • December 2018 (382)
  • November 2018 (378)
  • October 2018 (510)
  • September 2018 (297)
Powered by Blogger.

Report Abuse

Formulir Kontak



Search This Blog

Find Us On Facebook

Labels

  • Health News Today on Fox News
  • FOX NEWS
  • Fox News : Health
  • Health
  • Health News Today on Fox News
  • Healthy tips
  • NYT

Flickr Images

Most Popular

  • FOX NEWS: Losing weight could reduce breast cancer risk for women over 50, study finds
    Losing weight could reduce breast cancer risk for women over 50, study finds Overweight women over the age of 50 could see a reduction ...
  • Ozempic ‘microdosing’ is the new weight-loss trend: Should you try it?
    A new trend gaining popularity among people trying to lose weight is microdosing the diabetes medication Ozempic. With approximately 70% of...
  • Helping Stroke Patients Regain Movement in their Hands
    By BY PAM BELLUCK from NYT Health https://ift.tt/6uNPHMD
  • As eating disorders increase among college students, here's how parents can help: ‘Early intervention is key’
    While most of us have heard about the "Freshman 15" — the stereotypical first-year weight gain among college students — a growing ...
  • Pioneer of America's global HIV/AIDS program recalls hope after years of despair
    Through his office window at what was then one of Africa's few modern clinics dealing with HIV and AIDS , the man who now oversees the U...
  • Free COVID tests will again be available from US government starting next week
    The U.S. government is reactivating the program that mails free COVID-19 tests to Americans' homes upon request. Effective Sept. 25, h...
  • New COVID vaccine push is ‘anti-human,’ says Florida surgeon general: ‘Major safety concern’
    The new COVID-19 vaccine is now available at participating pharmacies and health care providers, and the Centers for Disease Control (CDC) ...
  • AI tech aims to help patients catch disease early even reverse their biological age
    In humanity's quest to live longer, healthier lives, technology — particularly artificial intelligence — is playing an ever-bigger role...
  • US scores D+ for preterm birth rates, says new report: ‘Falling further behind’
    The rate of preterm births remains alarmingly high in the U.S., according to the latest March of Dimes Report Card. The figure was around ...
  • FOX NEWS: Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit
    Vermont fertility doctor accused of using his own sperm to inseminate woman 41 years ago: lawsuit A child conceived in 1977 through art...

Sample Text

Copyright © 2025 Health | Powered by Blogger
Design by Hardeep Asrani | Blogger Theme by NewBloggerThemes.com | Distributed By Gooyaabi Templates